Previous Article | Next Article ![]()
Journal of Virology, February 2005, p. 1523-1532, Vol. 79, No. 3
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.3.1523-1532.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Qingmei Jia,1,
Seii Ohka,1
Hitoshi Horie,2 and
Akio Nomoto1*
Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Hongo, Bunkyo-ku,1 Japan Poliomyelitis Research Institute, Kumegawa, Higashimurayama, Tokyo, Japan2
Received 20 May 2004/ Accepted 19 September 2004
The poliovirus (PV)-induced cytopathic effect (CPE) was blocked in neural cells but not in HeLa cells by the addition of monoclonal antibody (MAb) against PV or the human PV receptor (CD155) 2 h postinfection (hpi). Since each MAb has the ability to block viral infection, no CPE in PV-infected neural cells appeared to result from the blockade of multiple rounds of viral replication. Pulse-labeling experiments revealed that virus-specific protein synthesis proceeded 5 hpi with or without MAbs. However, in contrast to the results obtained without MAbs, virus-specific protein synthesis with MAbs was not detected 7 hpi. Shutoff of host translation was also not observed in the presence of MAbs. Western blot analysis showed that 2Apro, the viral protein which mediates the cleavage of eukaryotic translation initiation factor eIF4G, was still present 11 hpi. However, intact eIF4G appeared 11 hpi. An immunocytochemical study indicated that 2Apro was detected only in the nucleus 11 hpi. These results suggest that neural cells possess protective response mechanisms against PV infection as follows: (i) upon PV infection, neural cells produce a factor(s) to suppress PV internal ribosome entry site activity by 7 hpi, (ii) a factor which supports cap-dependent translation for eIF4G may exist in infected cells when no intact eIF4G is detected, and (iii) the remaining 2Apro is not effective in cleaving eIF4G because it is imported into the nucleus by 11 hpi.
Present address: Department of Biochemistry, McGill University, McIntyre Medical Sciences Building, Rm. 807, 3655 Drummond St., Montreal, Quebec, Canada H3G 1Y6.
Present address: Department of Molecular and Medical Pharmacology, CHS 23-120, University of California at Los Angeles, Los Angeles, CA 90095.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|